カテゴリー： Market Monitor Global, 世界, 産業機械/建設

リツキシマブの世界市場見通し2023年-2029年

◆英語タイトル：Rituximab Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY5826 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：76 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：機械&装置

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Rituximab Market 調査レポートは次の情報を含め、グローバルにおけるのリツキシマブ市場規模と予測を収録しています。・世界のリツキシマブ市場：売上、2018年-2023年、2024年-2029年
・世界のリツキシマブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のリツキシマブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「10ml」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

リツキシマブのグローバル主要企業は、Rocheなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、リツキシマブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のリツキシマブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のリツキシマブ市場：タイプ別市場シェア、2022年
・10ml、50ml

世界のリツキシマブ市場：用途別、2018年-2023年、2024年-2029年
世界のリツキシマブ市場：用途別市場シェア、2022年
・血液がん、自己免疫疾患、臓器移植

世界のリツキシマブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のリツキシマブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるリツキシマブのグローバル売上、2018年-2023年
・主要企業におけるリツキシマブのグローバル売上シェア、2022年
・主要企業におけるリツキシマブのグローバル販売量、2018年-2023年
・主要企業におけるリツキシマブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche

*************************************************************

・調査・分析レポートの概要
リツキシマブ市場の定義
市場セグメント
世界のリツキシマブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のリツキシマブ市場規模
世界のリツキシマブ市場規模：2022年 VS 2029年
世界のリツキシマブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのリツキシマブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のリツキシマブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：10ml、50ml
リツキシマブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血液がん、自己免疫疾患、臓器移植
リツキシマブの用途別グローバル売上・予測

・地域別市場分析
地域別リツキシマブ市場規模 2022年と2029年
地域別リツキシマブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche
...

Rituximab is a type of antibody therapy that can be used alone or with chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Rituximab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rituximab. This report contains market size and forecasts of Rituximab in global, including the following market information:
Global Rituximab Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rituximab Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Rituximab companies in 2022 (%)
The global Rituximab market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
10ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rituximab include Roche. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rituximab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rituximab Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Rituximab Market Segment Percentages, by Type, 2022 (%)
10ml
50ml
Global Rituximab Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Rituximab Market Segment Percentages, by Application, 2022 (%)
Hematological Cancers
Autoimmune Diseases
Organ Transplants
Global Rituximab Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Rituximab Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rituximab revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rituximab revenues share in global market, 2022 (%)
Key companies Rituximab sales in global market, 2018-2023 (Estimated), (MT)
Key companies Rituximab sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rituximab, market overview.
Chapter 2: Global Rituximab market size in revenue and volume.
Chapter 3: Detailed analysis of Rituximab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rituximab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rituximab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Rituximab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rituximab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rituximab Overall Market Size
2.1 Global Rituximab Market Size: 2022 VS 2029
2.2 Global Rituximab Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rituximab Sales: 2018-2029
3 Company Landscape
3.1 Top Rituximab Players in Global Market
3.2 Top Global Rituximab Companies Ranked by Revenue
3.3 Global Rituximab Revenue by Companies
3.4 Global Rituximab Sales by Companies
3.5 Global Rituximab Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rituximab Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rituximab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rituximab Players in Global Market
3.8.1 List of Global Tier 1 Rituximab Companies
3.8.2 List of Global Tier 2 and Tier 3 Rituximab Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Rituximab Market Size Markets, 2022 & 2029
4.1.2 10ml
4.1.3 50ml
4.2 By Type – Global Rituximab Revenue & Forecasts
4.2.1 By Type – Global Rituximab Revenue, 2018-2023
4.2.2 By Type – Global Rituximab Revenue, 2024-2029
4.2.3 By Type – Global Rituximab Revenue Market Share, 2018-2029
4.3 By Type – Global Rituximab Sales & Forecasts
4.3.1 By Type – Global Rituximab Sales, 2018-2023
4.3.2 By Type – Global Rituximab Sales, 2024-2029
4.3.3 By Type – Global Rituximab Sales Market Share, 2018-2029
4.4 By Type – Global Rituximab Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Rituximab Market Size, 2022 & 2029
5.1.2 Hematological Cancers
5.1.3 Autoimmune Diseases
5.1.4 Organ Transplants
5.2 By Application – Global Rituximab Revenue & Forecasts
5.2.1 By Application – Global Rituximab Revenue, 2018-2023
5.2.2 By Application – Global Rituximab Revenue, 2024-2029
5.2.3 By Application – Global Rituximab Revenue Market Share, 2018-2029
5.3 By Application – Global Rituximab Sales & Forecasts
5.3.1 By Application – Global Rituximab Sales, 2018-2023
5.3.2 By Application – Global Rituximab Sales, 2024-2029
5.3.3 By Application – Global Rituximab Sales Market Share, 2018-2029
5.4 By Application – Global Rituximab Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Rituximab Market Size, 2022 & 2029
6.2 By Region – Global Rituximab Revenue & Forecasts
6.2.1 By Region – Global Rituximab Revenue, 2018-2023
6.2.2 By Region – Global Rituximab Revenue, 2024-2029
6.2.3 By Region – Global Rituximab Revenue Market Share, 2018-2029
6.3 By Region – Global Rituximab Sales & Forecasts
6.3.1 By Region – Global Rituximab Sales, 2018-2023
6.3.2 By Region – Global Rituximab Sales, 2024-2029
6.3.3 By Region – Global Rituximab Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Rituximab Revenue, 2018-2029
6.4.2 By Country – North America Rituximab Sales, 2018-2029
6.4.3 US Rituximab Market Size, 2018-2029
6.4.4 Canada Rituximab Market Size, 2018-2029
6.4.5 Mexico Rituximab Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Rituximab Revenue, 2018-2029
6.5.2 By Country – Europe Rituximab Sales, 2018-2029
6.5.3 Germany Rituximab Market Size, 2018-2029
6.5.4 France Rituximab Market Size, 2018-2029
6.5.5 U.K. Rituximab Market Size, 2018-2029
6.5.6 Italy Rituximab Market Size, 2018-2029
6.5.7 Russia Rituximab Market Size, 2018-2029
6.5.8 Nordic Countries Rituximab Market Size, 2018-2029
6.5.9 Benelux Rituximab Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Rituximab Revenue, 2018-2029
6.6.2 By Region – Asia Rituximab Sales, 2018-2029
6.6.3 China Rituximab Market Size, 2018-2029
6.6.4 Japan Rituximab Market Size, 2018-2029
6.6.5 South Korea Rituximab Market Size, 2018-2029
6.6.6 Southeast Asia Rituximab Market Size, 2018-2029
6.6.7 India Rituximab Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Rituximab Revenue, 2018-2029
6.7.2 By Country – South America Rituximab Sales, 2018-2029
6.7.3 Brazil Rituximab Market Size, 2018-2029
6.7.4 Argentina Rituximab Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Rituximab Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Rituximab Sales, 2018-2029
6.8.3 Turkey Rituximab Market Size, 2018-2029
6.8.4 Israel Rituximab Market Size, 2018-2029
6.8.5 Saudi Arabia Rituximab Market Size, 2018-2029
6.8.6 UAE Rituximab Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Rituximab Major Product Offerings
7.1.4 Roche Rituximab Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
8 Global Rituximab Production Capacity, Analysis
8.1 Global Rituximab Production Capacity, 2018-2029
8.2 Rituximab Production Capacity of Key Manufacturers in Global Market
8.3 Global Rituximab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rituximab Supply Chain Analysis
10.1 Rituximab Industry Value Chain
10.2 Rituximab Upstream Market
10.3 Rituximab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rituximab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Rituximab in Global Market
Table 2. Top Rituximab Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Rituximab Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Rituximab Revenue Share by Companies, 2018-2023
Table 5. Global Rituximab Sales by Companies, (MT), 2018-2023
Table 6. Global Rituximab Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Rituximab Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Rituximab Product Type
Table 9. List of Global Tier 1 Rituximab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rituximab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Rituximab Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Rituximab Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Rituximab Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Rituximab Sales (MT), 2018-2023
Table 15. By Type - Global Rituximab Sales (MT), 2024-2029
Table 16. By Application – Global Rituximab Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Rituximab Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Rituximab Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Rituximab Sales (MT), 2018-2023
Table 20. By Application - Global Rituximab Sales (MT), 2024-2029
Table 21. By Region – Global Rituximab Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Rituximab Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Rituximab Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Rituximab Sales (MT), 2018-2023
Table 25. By Region - Global Rituximab Sales (MT), 2024-2029
Table 26. By Country - North America Rituximab Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Rituximab Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Rituximab Sales, (MT), 2018-2023
Table 29. By Country - North America Rituximab Sales, (MT), 2024-2029
Table 30. By Country - Europe Rituximab Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Rituximab Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Rituximab Sales, (MT), 2018-2023
Table 33. By Country - Europe Rituximab Sales, (MT), 2024-2029
Table 34. By Region - Asia Rituximab Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Rituximab Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Rituximab Sales, (MT), 2018-2023
Table 37. By Region - Asia Rituximab Sales, (MT), 2024-2029
Table 38. By Country - South America Rituximab Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Rituximab Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Rituximab Sales, (MT), 2018-2023
Table 41. By Country - South America Rituximab Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Rituximab Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Rituximab Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Rituximab Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Rituximab Sales, (MT), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Rituximab Product Offerings
Table 48. Roche Rituximab Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Rituximab Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 51. Global Rituximab Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Rituximab Production by Region, 2018-2023 (MT)
Table 53. Global Rituximab Production by Region, 2024-2029 (MT)
Table 54. Rituximab Market Opportunities & Trends in Global Market
Table 55. Rituximab Market Drivers in Global Market
Table 56. Rituximab Market Restraints in Global Market
Table 57. Rituximab Raw Materials
Table 58. Rituximab Raw Materials Suppliers in Global Market
Table 59. Typical Rituximab Downstream
Table 60. Rituximab Downstream Clients in Global Market
Table 61. Rituximab Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rituximab Segment by Type in 2022
Figure 2. Rituximab Segment by Application in 2022
Figure 3. Global Rituximab Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rituximab Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rituximab Revenue, 2018-2029 (US$, Mn)
Figure 7. Rituximab Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Rituximab Revenue in 2022
Figure 9. By Type - Global Rituximab Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Rituximab Revenue Market Share, 2018-2029
Figure 11. By Type - Global Rituximab Sales Market Share, 2018-2029
Figure 12. By Type - Global Rituximab Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Rituximab Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Rituximab Revenue Market Share, 2018-2029
Figure 15. By Application - Global Rituximab Sales Market Share, 2018-2029
Figure 16. By Application - Global Rituximab Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Rituximab Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Rituximab Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Rituximab Revenue Market Share, 2018-2029
Figure 20. By Region - Global Rituximab Sales Market Share, 2018-2029
Figure 21. By Country - North America Rituximab Revenue Market Share, 2018-2029
Figure 22. By Country - North America Rituximab Sales Market Share, 2018-2029
Figure 23. US Rituximab Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Rituximab Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Rituximab Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Rituximab Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Rituximab Sales Market Share, 2018-2029
Figure 28. Germany Rituximab Revenue, (US$, Mn), 2018-2029
Figure 29. France Rituximab Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Rituximab Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Rituximab Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Rituximab Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Rituximab Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Rituximab Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Rituximab Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Rituximab Sales Market Share, 2018-2029
Figure 37. China Rituximab Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Rituximab Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Rituximab Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Rituximab Revenue, (US$, Mn), 2018-2029
Figure 41. India Rituximab Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Rituximab Revenue Market Share, 2018-2029
Figure 43. By Country - South America Rituximab Sales Market Share, 2018-2029
Figure 44. Brazil Rituximab Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Rituximab Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Rituximab Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Rituximab Sales Market Share, 2018-2029
Figure 48. Turkey Rituximab Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Rituximab Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Rituximab Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Rituximab Revenue, (US$, Mn), 2018-2029
Figure 52. Global Rituximab Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Rituximab by Region, 2022 VS 2029
Figure 54. Rituximab Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ リツキシマブの世界市場見通し2023年-2029年(Rituximab Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

リツキシマブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp